Jérôme de Sèze to Disease Progression
This is a "connection" page, showing publications Jérôme de Sèze has written about Disease Progression.
Connection Strength
0.131
-
Outcomes and treatment management of a French cohort suffering from multiple sclerosis: A retrospective epidemiological study. Mult Scler Relat Disord. 2018 Oct; 25:276-281.
Score: 0.048
-
Relapsing optic neuritis: a multicentre study of 62 patients. Mult Scler. 2014 06; 20(7):848-53.
Score: 0.034
-
Inaugural tumor-like multiple sclerosis: clinical presentation and medium-term outcome in 87 patients. J Neurol. 2018 Oct; 265(10):2251-2259.
Score: 0.012
-
An autophagy-targeting peptide to treat chronic inflammatory demyelinating polyneuropathies. J Autoimmun. 2018 08; 92:114-125.
Score: 0.012
-
Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis. PLoS One. 2017; 12(1):e0168834.
Score: 0.011
-
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis. N Engl J Med. 2017 01 19; 376(3):209-220.
Score: 0.011
-
[Treatment of progressive multiple sclerosis with cyclophosphamide]. Rev Neurol (Paris). 2002 Jan; 158(1):65-9.
Score: 0.004